Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,971.00
Bid: 1,971.00
Ask: 1,972.00
Change: -29.00 (-1.45%)
Spread: 1.00 (0.051%)
Open: 2,008.00
High: 2,012.00
Low: 1,958.00
Prev. Close: 2,000.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Potential strike on Syria worries investors early on

Wed, 04th Sep 2013 08:32

Stocks declined on Wednesday morning on concerns over an imminent Western military intervention in Syria, with investors also choosing to scale back positions ahead of a number of 'risk events' later on in the week.The Senate Foreign Relations Committee last night gave the green light on a US attack on Syria, saying that the use of force "reflects the will and concerns of Democrats and Republicans alike".The backing of the Committee "reminded investors that the potential for war is still lurking", according to Financial Trader Shavaz Dhalla from Spreadex.This comes ahead of the crucial vote in Congress next week on President Barack Obama's call for action against the Bashar al-Assad regime which he claims is responsible for the deadly chemical weapons attack against the Syrian people in August.Dhalla said: "Many now believe that if a strike is approved, this would likely occur in a much smaller scale and involve a fewer number of countries than initially expected. Despite this, the possible legal repercussions from Syria's allies, which include China and Russia, if the strike does happen without UN approval is still troubling investors."Traders will also be cautious today ahead of three central-bank meetings tomorrow from the Bank of Japan, Bank of England and the European Central Bank. These will be followed by the all-important US jobs report on Friday which will be a large factor in the Federal Reserve's decision on whether or not to adjust current stimulus measures later this month.FTSE 100: Airline stocks sink after Ryanair profit warningAirline peers easyJet and IAG were flying lower this morning after a gloomy outlook by Ryanair on the back of the hot weather in Northern Europe over the summer. The company scaled back its full-year profit guidance after worse-than-expected bookings but said that it could even fail to meet these forecasts if fares and yields continue to weaken over the coming winter.Hargreaves Lansdown fell despite reporting record annual figures this morning. Full-year pre-tax profit rose 28% to £195.2m as the financial services company took on more clients and increased assets under administration by 38% rise in AuA to £36.4bn. Weighing on the price this morning could be Morgan Stanley's downgrade of the 'Diversified Financial' sector to 'neutral'.TUI Travel, Resolution and BHP Billiton were also heavy fallers this morning after going ex-dividend, meaning that from today new investors won't be able to get their hands on their latest dividend payments. Others that went ex-dividend on the blue-chip index include Admiral, Aggreko, ARM Holdings, IMI, Land Securities, Serco Group and Shire.Chemicals group Croda International also went ex-div today but was trading higher after Exane BNP Paribas upgraded its rating on the stock to 'outperform'.British Land fell after saying it is set to purchase 50% of 430,000 square-foot SouthGate retail space in Bath by paying current owner Multi Southgate £101m.FTSE 250: Phoenix lower after going ex-divClosed life and pension fund consolidator Phoenix was the worst performer this morning after going ex-dividend. A host of others were also trading without the rights to their latest payouts, including 888 Holdings, Betfair, Elementis, esure, Greggs, Hikma Pharmaceuticals, Jardine Lloyd Thompson, Michael Page International, Micro Focus International, National Express Group, Polymetal International, Regus, SEGRO and Xaar.Ashtead Group rose after the equipment rental company booked a 24% increase in first-quarter revenue amid strong demand and a tight control on costs. It now expects a full-year result ahead of previous expectations. Kenmare Resources was higher after Goldman raised its recommendation to 'conviction buy', while Salamander Energy was boosted by a Morgan Stanley upgrade to 'equalweight'.FTSE 100 - RisersVodafone Group (VOD) 206.30p +1.88%Fresnillo (FRES) 1,295.00p +1.33%Experian (EXPN) 1,147.00p +1.15%HSBC Holdings (HSBA) 691.50p +0.57%BG Group (BG.) 1,252.50p +0.44%Shire Plc (SHP) 2,396.00p +0.38%Petrofac Ltd. (PFC) 1,401.00p +0.36%Serco Group (SRP) 551.50p +0.27%Johnson Matthey (JMAT) 2,924.00p +0.24%WPP (WPP) 1,236.00p +0.24%FTSE 100 - FallerseasyJet (EZJ) 1,190.00p -7.03%International Consolidated Airlines Group SA (CDI) (IAG) 282.60p -4.11%Resolution Ltd. (RSL) 312.20p -4.06%TUI Travel (TT.) 333.50p -3.53%Hargreaves Lansdown (HL.) 998.00p -3.20%BHP Billiton (BLT) 1,887.50p -2.51%William Hill (WMH) 405.90p -2.17%Carnival (CCL) 2,339.00p -1.93%Persimmon (PSN) 1,121.00p -1.84%Associated British Foods (ABF) 1,867.00p -1.79%FTSE 250 - RisersBumi (BUMI) 220.50p +5.65%Kenmare Resources (KMR) 28.30p +4.04%UK Commercial Property Trust (UKCM) 76.45p +1.80%Salamander Energy (SMDR) 131.40p +1.78%JPMorgan Indian Inv Trust (JII) 294.60p +1.73%Fisher (James) & Sons (FSJ) 1,109.00p +1.46%Big Yellow Group (BYG) 414.40p +1.44%F&C Commercial Property Trust Ltd. (FCPT) 115.50p +1.32%Daejan Holdings (DJAN) 3,818.00p +1.14%Dixons Retail (DXNS) 44.67p +1.11%FTSE 250 - FallersPhoenix Group Holdings (DI) (PHNX) 713.50p -5.50%Thomas Cook Group (TCG) 137.00p -3.93%Micro Focus International (MCRO) 741.50p -3.76%Barratt Developments (BDEV) 305.20p -3.11%Menzies(John) (MNZS) 770.00p -3.02%Mitchells & Butlers (MAB) 434.00p -2.95%Taylor Wimpey (TW.) 100.10p -2.91%Carillion (CLLN) 283.80p -2.64%Ashtead Group (AHT) 669.50p -2.62%Amlin (AML) 380.30p -2.46%BC
More News
27 Aug 2021 12:32

Hikma, Bio-Thera enter exclusive agreement for monoclonal antibody

(Sharecast News) - Bio-Thera Solutions and Hikma Pharmaceuticals have entered into a commercialisation and license agreement to commercialise a monoclonal antibody used for the treatment of Crohn's disease.

Read more
20 Aug 2021 09:46

LONDON BROKER RATINGS: Peel Hunt ups InterContinental Hotels to Hold

LONDON BROKER RATINGS: Peel Hunt ups InterContinental Hotels to Hold

Read more
20 Aug 2021 08:10

LONDON BRIEFING: Softbank's Fortress doesn't give up on Morrisons

LONDON BRIEFING: Softbank's Fortress doesn't give up on Morrisons

Read more
17 Aug 2021 09:46

UPDATE 2-Energy, healthcare stocks lift FTSE 100; BHP Group shines

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* UK employment closer to pre-pandemic levels* BHP Group jumps on strong results* PLUS500 gains on robust revenue forecasts* FTSE 100 up 0.3%...

Read more
12 Aug 2021 16:04

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
6 Aug 2021 17:06

LONDON MARKET CLOSE: FTSE 100 boosted by strong US jobs report

LONDON MARKET CLOSE: FTSE 100 boosted by strong US jobs report

Read more
6 Aug 2021 12:07

LONDON MARKET MIDDAY: Caution dominates ahead of US nonfarm payrolls

LONDON MARKET MIDDAY: Caution dominates ahead of US nonfarm payrolls

Read more
6 Aug 2021 09:03

LONDON MARKET OPEN: Stocks soft, dollar up as US nonfarm payrolls near

LONDON MARKET OPEN: Stocks soft, dollar up as US nonfarm payrolls near

Read more
6 Aug 2021 08:40

TOP NEWS: Hikma hikes Generics guidance as interim profit swells

TOP NEWS: Hikma hikes Generics guidance as interim profit swells

Read more
6 Aug 2021 07:42

LONDON MARKET PRE-OPEN: LSEG raises Refinitiv cost synergy guidance

LONDON MARKET PRE-OPEN: LSEG raises Refinitiv cost synergy guidance

Read more
6 Aug 2021 07:22

Hikma lifts FY generics guidance as first-half profits, revenue jump

(Sharecast News) - Hikma Pharmaceuticals upgraded full-year guidance for its generics arm and reported a rise in first-half profit and revenue as it hailed a strong performance in both the generics and branded segments, and resilience in the injectables business.

Read more
30 Jul 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
14 Jul 2021 19:38

IN BRIEF: Arecor ends first half of 2021 with solid cash position

IN BRIEF: Arecor ends first half of 2021 with solid cash position

Read more
13 Jul 2021 10:00

BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight

BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight

Read more
1 Jul 2021 09:51

BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart

BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.